Director, Global Medical Cardiovascular, Mavacamten

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . Position Summary The Director, Global Medical Cardiovascular, Mavacamten is a key medical leader responsible for shaping and executing both Worldwide and US medical strategy for mavacamten across its lifecycle in hypertrophic cardiomyopathy (HCM). This role provides scientific and clinical leadership across global and US medical initiatives, including medical strategy development, evidence planning, publications, congress strategy, medical education, external communications, and cross‑functional scientific engagement. The Director leads in a highly collaborative environment with a diverse matrix.  The Director partners closely with Regional Market Medical, Medical Communications, Clinical Development, Regulatory, Safety, Market Access, Marketing and Commercial teams, requiring strong cross‑functional leadership to ensure medical strategies are aligned, scientifically rigorous, clinically meaningful, and responsive to the evolving HCM landscape. Key Responsibilities Lead development and execution of integrated Worldwide and US medical strategies for mavacamten across indications and lifecycle stages Partner closely with Medical Market Leads to translate global medical strategy into region - specific medical plans detailing clear executional priorities Drive alignment across cross‑functional stakeholders to ensure medical strategy informs and is informed by development, regulatory, access, and commercialization considerations Serve as a global and US medical subject matter expert in hypertrophic cardiomyopathy Provide leadership for global and US content generation strategy, disease education strategy, and data interpretation Act as a trusted cross‑functional medical advisor, providing clear scientific guidance and clinical context to internal stakeholders Contribute to Worldwide and US evidence planning, including RWE, Phase 4 studies, registries, and investigator‑sponsored research as needed Support global and US publication and content strategy, including review of abstracts, manuscripts, congress materials, and externally-facing resources.  Participate in medical review processes for promotional and non‑promotional materials, as required Provide medical leadership for global and US congress strategy and execution Partner with Global, US and regional medical teams to establish and maintain long-term Thought Leader Engagement Strategy.  Manages Global Thought Leader activities, including Advisory Boards - aligns with functions, markets, and regions to ensure transparency regarding TL activities  Coordinate with cross‑functional partners to ensure scientific engagement strategies are aligned and appropriately governed Act as a core member of the Worldwide–US mavacamten medical and commercialization matrix teams Demonstrate strong cross‑functional leadership in a highly matrixed environment, influencing without authority and driving alignment across Medical, Clinical Development, Regulatory, Safety, Market Access, Marketing and Commercial teams Support medical training initiatives and ensure consistency of scientific messaging across Global and US teams Ensure all Worldwide and US medical activities comply with company policies and medical governance standards Qualifications & Experience Advanced scientific degree (MD, PhD, PharmD, PA/NP) At least 5-10 years of experience in Medical Affairs within pharmaceutical or biotech with increasing responsibility Experience supporting both global and US medical strategy strongly preferred Cardiovascular disease expertise required; HCM or rare disease experience strongly preferred Demonstrated success partnering cross‑functionally in complex, matrixed organizations Prior industry experience in CV Medical affairs/Medical Strategy, Product launch and Clinical Research or related experience is preferred. Must have experience working in multi-functional project team and managing external agencies.   Proven ability to plan and implement medical congresses and advisory boards.  Familiarity with all phases of drug development is desirable Skills & Competencies Strong scientific and clinical acumen with the ability to translate data into actionable medical strategy Ability to work effectively with cross functional teams including clinical, commercialization, regulatory and early discovery.  The successful candidate must be highly professional with excellent relationship-building and communication skills, including the ability to articulate both verbally and in writing complex scientific principles.  Ability to navigate ambiguity and align diverse stakeholders around shared medical objectives Acts with the highest level of leadership with Enterprise Mindset and flexibility  Attention to detail with excellent planning, time management and organizational skills   Resiliency and strong adaptability to change  High-level negotiation skills and the ability to resolve conflict in a constructive manner   Innovative and entrepreneurial thinking  Functions with excellent judgment, high integrity and in compliance with